Three Immunosuppressive Treatment Regimens for Severe Aplastic Anemia

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Heart, Lung, and Blood Institute (NHLBI) )
ClinicalTrials.gov Identifier:
NCT00260689
First received: December 1, 2005
Last updated: June 25, 2014
Last verified: May 2014